Edwardson, Charlotte L.
Biddle, Stuart J. H.
Clarke-Cornwell, Alexandra
Clemes, Stacy
Davies, Melanie J.
Dunstan, David W.
Eborall, Helen
Granat, Malcolm H.
Gray, Laura J.
Healy, Genevieve N.
Richardson, Gerry
Yates, Thomas
Munir, Fehmidah
Funding for this research was provided by:
National Institute for Health Research (16.41.04)
Article History
Received: 13 August 2018
Accepted: 4 September 2018
First Online: 14 September 2018
Ethics approval and consent to participate
: The study was approved by the University of Leicester’s College of Life Sciences and the University of Salford’s Research, Enterprise and Engagement Ethical Approval Panel. All study amendments will be sent to the Sponsor and the ethics Chair at Leicester and Salford for approval. Current protocol approved is version 1.5 dated 15/06/2018. All participants will provide written informed consent.
: Not applicable
: CLE is an Associate Editor for BMC Public Health. DWD reports grants from National Health and Medical Research Council (Australia), and Victorian Health Promotion Foundation (VicHealth) during the conduct of the study. MJD reports personal fees from Novo Nordisk, personal fees from Sanofi-Aventis, Lilly, Merck Sharp & Dohme, Boehringer Ingelheim, AstraZeneca, Janssen, Servier, Mitsubishi Tanabe Pharma Corporation, and Takeda Pharmaceuticals International Inc., grants from Novo Nordisk, Sanofi-Aventis, Lilly, Boehringer Ingelheim, and Janssen outside the submitted work. GNH is supported by an Australian National Health and Medical Research Council: NHMRC Career Development Fellowship [grant number 108029].
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.